Skip to main content
HOWL
NASDAQ Life Sciences

Institutional Investor Files Intent to Sell $123K in Shares Amid Ongoing Exit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.495
Mkt Cap
$24.07M
52W Low
$0.493
52W High
$2.38
52W Position info
0.4% above low
Off High info
79% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

HOWL is trading near its 52-week low of $0.493 (0.4% above the low).

Summary

UBS Oncology Impact Fund, L.P., an institutional shareholder, filed a Form 144 indicating intent to sell approximately $123,768 worth of common stock, continuing a pattern of institutional distribution.


Key Events · Ownership and Investor Activity · HOWL

  • Intent to Sell Shares

    UBS Oncology Impact Fund, L.P. filed a Form 144 to sell 240,280 shares of common stock, valued at approximately $123,768.

  • Continuation of Institutional Exit

    This filing follows a series of recent Form 144s and Schedule 13D/A filings by institutional investors, including MPM BioVentures and RA Capital, indicating ongoing significant sales totaling over $800,000 in the past month.

  • Distressed Company Context

    The company previously disclosed substantial doubt about its ability to continue as a going concern and is exploring strategic alternatives, making continued institutional selling particularly notable.

  • Trading Near 52-Week Lows

    The proposed sale occurs while the stock is trading near its 52-week low, reinforcing the negative sentiment from institutional exits.


Analysis · HOWL · Life Sciences

This Form 144 from UBS Oncology Impact Fund, L.P. signals a continuation of institutional investors reducing their exposure to Werewolf Therapeutics. While the individual transaction value of $123,768 is modest, it adds to a pattern of significant sales by major institutional holders, including MPM BioVentures and RA Capital, totaling over $800,000 in the past month. This ongoing distribution is particularly concerning given the company's recent disclosure of substantial doubt about its ability to continue as a going concern and its exploration of strategic alternatives. The fact that these sales are occurring while the stock trades near its 52-week low suggests a lack of confidence from these large shareholders.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $24.1M. The 52-week trading range was $0.49 to $2.38. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.9836
Real-time Price: $1.04 info
Change: +$0.0564 (+6%) info
Market Cap: $51.029M info
HOWL
Nov 10, 2026, 4:37 PM EST
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $1.04 info
Change: +$0.070 (+7%) info
Market Cap: $51.029M info
HOWL
Nov 09, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $1.04 info
Change: +$0.040 (+4%) info
Market Cap: $51.029M info
HOWL
Oct 26, 2026, 5:23 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.9806
Real-time Price: $1.04 info
Change: +$0.0594 (+6%) info
Market Cap: $51.029M info
HOWL
Sep 22, 2026, 5:04 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $0.9707
Real-time Price: $1.04 info
Change: +$0.0693 (+7%) info
Market Cap: $51.029M info